<p>In this episode of the podcast, Joe interviews James Lanthier, the CEO of Mindset Pharma; a biotechnology company discovering and developing new (and hopefully safer, more predictable, and more palatable) psychedelic compounds.</p> <p>www.psychedelicstoday.com</p>

In this episode of the podcast, Joe interviews James Lanthier, the CEO of Mindset Pharma; a biotechnology company discovering and developing new (and hopefully safer, more predictable, and more palatable) psychedelic compounds. www.psychedelicstoday.com

PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.

Share PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

Sign up to save your podcasts

PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

More shows like Psychedelics Today

Sounds True: Insights at the Edge

Ram Dass Here And Now

Aubrey Marcus Podcast

Mindrolling with Raghu Markus

Buddha at the Gas Pump

Heart Wisdom with Jack Kornfield

THIRD EYE DROPS

The Psychedelic Podcast

This Jungian Life Podcast

New Thinking Allowed Audio Podcast

Back from the Abyss: Psychiatry in Stories

Plants of the Gods: Hallucinogens, Healing, Culture and Conservation podcast

Psychedelic Therapy Frontiers

Sounds of SAND

The Telepathy Tapes